Literature DB >> 19784660

Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients.

Aras Emre Canda1, Cem Terzi, Ilknur B Gorken, Ilhan Oztop, Selman Sokmen, Mehmet Fuzun.   

Abstract

PURPOSE: Deterioration of anorectal function after long-course preoperative chemoradiotherapy combined with surgery for rectal cancer is poorly defined. We conducted a prospective study to evaluate the acute and long term effects of preoperative chemoradiotherapy on anorectal function and quality of life of the patients.
METHODS: There were 26 patients in surgery group and 31 patients in preoperative chemoradiotherapy group. Anorectal function and quality of life of the patients were assessed by anorectal manometry, incontinence score, quality of life questionnaire.
RESULTS: Significant lower resting pressures in both groups and lower maximal squeeze pressures in the preoperative chemoradiotherapy group were observed after postsurgical evaluations compared with the paired pretreatment ones. In the surgery group, both the Wexner continence score, FIQL score, and the rectoscopy score were comparable before and after surgery, whereas significant worsening in the Wexner score was observed in the preoperative chemoradiotherapy group postoperatively (P < 0.01). Significant reduction in anal canal resting pressures and squeeze pressures, Wexner score, and FIQL score were observed immediately after the completion of preoperative chemoradiotherapy. Significant lower maximal squeeze pressures and worsening of the Wexner scores were observed in the preoperative chemoradiotherapy group compared to the surgery group during the postoperative assessments (P < 0.05 and P < 0.01, respectively).
CONCLUSIONS: Both total mesorectal excision and preoperative chemoradiotherapy may adversely affect the anorectal function. Careful selection of the patients who will benefit from neoadjuvant therapy and identifying the patients with a high risk of developing functional problems may help to improve functional outcomes for the treatment of rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784660     DOI: 10.1007/s00384-009-0807-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  25 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  Long-term effect of preoperative radiation therapy on anorectal function.

Authors:  Johan Pollack; Torbjörn Holm; Björn Cedermark; Bo Holmström; Anders Mellgren
Journal:  Dis Colon Rectum       Date:  2006-03       Impact factor: 4.585

4.  Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency.

Authors:  Jit F Lim; Joe J Tjandra; Richard Hiscock; Michael W T Chao; Peter Gibbs
Journal:  Dis Colon Rectum       Date:  2006-01       Impact factor: 4.585

5.  Adjuvant therapy for rectal cancer--a good first step.

Authors:  B D Minsky
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

Review 6.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

7.  Correlation of clinical and manometric abnormalities of rectal function following chronic radiation injury.

Authors:  J S Varma; A N Smith; A Busuttil
Journal:  Br J Surg       Date:  1985-11       Impact factor: 6.939

8.  The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

Authors:  Vincenzo Valentini; Bengt Glimelius; Bruce D Minsky; Eric Van Cutsem; Hanry Bartelink; Regina G H Beets-Tan; Jean-Pierre Gerard; Paris Kosmidis; Lars Pahlman; Aurelio Picciocchi; Phil Quirke; Joel Tepper; Maurizio Tonato; Cornelius J Van de Velde; Numa Cellini; Paolo Latini
Journal:  Radiother Oncol       Date:  2005-09       Impact factor: 6.280

9.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

10.  Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up.

Authors:  R Wagman; B D Minsky; A M Cohen; J G Guillem; P P Paty
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

View more
  21 in total

Review 1.  Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Authors:  Irshad Shaikh; Alan Askari; Suzana Ourû; Janindra Warusavitarne; Thanos Athanasiou; Omar Faiz
Journal:  Int J Colorectal Dis       Date:  2014-11-04       Impact factor: 2.571

2.  Manometric assessment of anorectal function after transanal total mesorectal excision.

Authors:  M X Bjoern; S K Perdawood
Journal:  Tech Coloproctol       Date:  2020-02-01       Impact factor: 3.781

3.  Long-Term Functional and Oncological Outcomes Following Intersphincteric Resection for Low Rectal Cancers.

Authors:  Sivakumar Mahalingam; Ramakrishnan Ayloor Seshadri; Surendran Veeraiah
Journal:  Indian J Surg Oncol       Date:  2016-10-28

4.  Coloanal anastomosis or abdominoperineal resection for very low rectal cancer: what will benefit, the surgeon's pride or the patient's quality of life?

Authors:  Rosa Digennaro; Mirna Tondo; Filippa Cuccia; Ivana Giannini; Francesco Pezzolla; Marcella Rinaldi; Dario Scala; Giovanni Romano; Donato F Altomare
Journal:  Int J Colorectal Dis       Date:  2012-12-30       Impact factor: 2.571

5.  Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers.

Authors:  Xue Bai; Shiyong Li; Bo Yu; Hong Su; Weisen Jin; Gang Chen; Junfeng DU; Fuyi Zuo
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

6.  Quality of life after laparoscopic vs open sphincter-preserving resection for rectal cancer.

Authors:  Simon Siu-Man Ng; Wing-Wa Leung; Cherry Yee-Ni Wong; Sophie Sok-Fei Hon; Tony Wing-Chung Mak; Dennis Kwok-Yu Ngo; Janet Fung-Yee Lee
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

7.  Differences in short-term outcomes among patients undergoing IPAA with or without preoperative radiation: a National Surgical Quality Improvement Program analysis.

Authors:  Brittany E Wertzberger; Scott K Sherman; John C Byrn
Journal:  Dis Colon Rectum       Date:  2014-10       Impact factor: 4.585

8.  Development of a dual-energy spectral computed tomography-based nomogram for the preoperative discrimination of histological grade in colorectal adenocarcinoma patients.

Authors:  Yuntai Cao; Guojin Zhang; Haihua Bao; Jialiang Ren; Zhan Wang; Jing Zhang; Zhiyong Zhao; Xiaohong Yan; Yanjun Chai; Junlin Zhou
Journal:  J Gastrointest Oncol       Date:  2021-04

9.  Intersphincteric resection and coloanal anastomosis in treatment of distal rectal cancer.

Authors:  Gokhan Cipe; Mahmut Muslumanoglu; Erkan Yardimci; Naim Memmi; Erhan Aysan
Journal:  Int J Surg Oncol       Date:  2012-05-29

10.  A study on the clinical application of greater omental pedicle flap transplantation to correct anterior resection syndrome in patients with low rectal cancer.

Authors:  Haiquan Qin; Linghou Meng; Zigao Huang; Jiankun Liao; Yan Feng; Shanshan Luo; Hao Lai; Weizhong Tang; Xianwei Mo
Journal:  Regen Ther       Date:  2021-06-17       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.